We all knew that 1/3 of the U.S. population was obese and that 1/3 of our kids are already obese. But, JAMA reports it’s much worse than that — over 1/3 of the U.S. population has metabolic syndrome. In other words, that belly bulge has already given 1/3 of the U.S. population type 2 diabetes and hypertension and narrowed their carotid arteries so they get a stroke or is going to! Not only scary but expensive. Until now, the only abdominal or belly fat we could remove was omental fat, a not an altogether benign procedure, but a procedure shown to improve metabolism. Mesenteric fat has been shown to be more metabolically hazardous than omental fat and its accumulation directly correlated with the severity of carotid narrowing. Endoscopic visceral lipectomy can give us a way to remove this fat safely and effectively for the very first time. BioSculpture Technology, Inc. (“BST”) filed its answer to a first round of SEC comments on its Form 1-A for a Tier 2 Reg. A Offering to fund development and clinical testing of its minimally invasive EVL® device for the endoscopic removal of visceral or “belly” fat, as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus. We believe our patented technology and procedure, Endoscopic Visceral Lipectomy (“EVL”) to remove this noxious fat, illustrated in this 70 second medical video, will save and improve millions of lives each year, while significantly reducing healthcare costs.

medical video

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: